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Background/objectives: To study temporal trends in crude and age standardised rates of cardiac catheterisation
and percutaneous coronary intervention (PCI) in Ireland, 2004–2011.
Methods: Twodata sourceswere used: a) a survey of publicly andprivately fundedhospitalswith cardiac catheter
laboratories to obtain the annual number of procedures performed and b) anonymised data from the Hospital In-
Patient Enquiry (HIPE) for angiography and PCI in acute publicly funded hospitals; age standardised rates were
calculated to study trends over time.
Results: From2004 to 2011 the crude rate of angiography and PCI increased by 47.8% and 35.9% respectively, with
rates of 6689 and 1825 per million population in 2011. Following age standardisation, however, PCI activity
showed a non-signiﬁcant decrease over time. The PCI to angiography ratio decreased from 30% to 27% and PCI
was performed predominantly for stable coronary heart disease (54%) in 2011.
Conclusion:Angiography and PCI rates have increased in Ireland but PCI crude and age adjusted rates showdiver-
gent trends. While Ireland differs from USA and UK, with a higher proportion of PCI being performed for stable
CHD in recent years, little systematic surveillance of cardiological interventions within Europe is available to
benchmark improvements in Ireland.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Background/objectives
Since PCI was ﬁrst performed in 1977, it has undergone rapid evolu-
tion to become one of the most widely performed medical procedures,
currently over 3million annually worldwide [1]. PCI is a highly effective
means of treating acute coronary disease. However its application as ini-
tial therapy in patients with stable disease is not superior to optimal
medical therapy [2] and it is not as effective as CABG in patients with
highly complex disease, particularly those with diabetes requiring
multivessel revascularisation [3]. The evaluation of coronary disease
has also evolved and contemporary clinical practice guidelines, such as
the ESC guideline for Stable Coronary Disease 2012 [4], emphasise the
importance of amore robust approach to the selection of patients for in-
vasive angiography than simple treadmill testing (or no functional test
at all), using pre-test risk stratiﬁcation and stress imaging techniques
where appropriate. In view of the steady streamof evidence challenging
certain aspects of contemporary practice it is all the more surprising, Dr SteevensHospital, Steevens
353 1 6352103.
.
land Ltd. This is an open access articlthat few comparative data on the temporal trend in provision of
catherisations and interventions are available, especially at a population
level. This is particularly true for European countries. There are a
number of studies from the USA,with themore recentwork speculating
that the volume of PCIs has started to decline [5].
Ireland has experienced signiﬁcant improvements in the burden of
disease from coronary heart disease (CHD) —mortality decreased after
the mid-1980s [6] with previous work attributing the decrease in CHD
mortality to both improvements in treatment uptake and changes in
levels of the main cardiovascular risk factors [7]. Further a reduction in
acute myocardial infarction hospitalisation rate has been reported with
a decrease in ST elevationmyocardial infarction (STEMI) hospitalisations
and an increase in non-ST elevation myocardial infarction (NSTEMI)
hospitalisation due to increased survival and an ageing population [8].
The ﬁrst national cardiovascular policy in 1999 [9] recommended invest-
ment in cardiac catheterisation suites in Ireland and was followed by
growth in public and private catheterisation facilities. To date little has
been documented about the characteristics of this evolving and
expensive service.
To understand temporal trends in cardiac interventions in Ireland,
we examined angiography and PCI numbers and rates from 2004 toe under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
36 S. Jennings et al. / IJC Heart & Vessels 4 (2014) 35–392011. Speciﬁcally we aimed to study: a) the time trend in number and
rate (crude rate per million and age standardised rates) of angiography
and percutaneous coronary intervention (PCI) provision in private and
publicly funded hospitals and b) the epidemiological features (age,
gender) of angiography and PCI provision in Irish publicly funded hospi-
tals in the context of development of cardiac catheter laboratories in
Ireland over the same period.2. Methods
Ireland has a two tiered health system with public and private
provision. Access to healthcare in Ireland is either via eligibility for a
medical card permitting access to a wide range of health services and
medicines free of charge (36% in 2010) or for the rest of the population
to a range of community and hospital health services, either free of
charge or at reduced cost. In addition, private health insurance to
facilitate choice of access to private care in either publicly funded or
private hospitals was held by 49% of the population in 2007 falling to
47% in 2010 [10].
Cardiac catherisation procedures are carried out in both publicly and
privately funded hospitals. Two data streams were employed in this
study. The ﬁrst, a survey of aggregate data from all publicly funded
and private hospitals with cardiac catheter laboratories in Ireland over
the period 2004–2011 provided a picture of procedural activity in the
country. The second, using routine data from publicly funded hospitals
on individual hospitalisations allowed age standardised analysis.
The survey requested hospitals to provide aggregate data on proce-
dures undertaken each year in their labs, in patients aged 20 years and
over, for the years 2004–2011. A standard questionnaire was employed
to collect the number of angiograms and PCIs as well as the number of
catheter labs.
The second source employed cross-sectional data on hospi-
talisations, including procedures and diagnosis extracted from the Eco-
nomic and Social Research Institute's (ESRI) national Hospital In-Patient
Enquiry (HIPE) system covering care in all publicly funded acute hospi-
tals. All participatinghospitals use the samedataset and software,with a
range of procedures directed at safeguarding data quality integrated
into the software [11]. The data coverage in HIPE exceeds 96% in these
hospitals. Private hospitals (n = 9) do not contribute to HIPE. Also, pri-
vate hospitals, until the late 2000s, lacked emergency departments
resulting in few treatments for acute coronary syndrome (B Maurer,
personal communication).
Data extracted fromHIPE covered the years 2004–2011. ICD-9 codes
were used for 2004 (PCI codes 3601, 3602, 3605; angiography codes
38215.00, 38218.00–38518.02; IHD diagnosis codes 410, 411, 412,
413, 414) and ICD-10 codes for 2005 onwards (PCI codes 38300,
38303, 38306; angiography codes 8850, 8852–8858; CHD diagnosis
codes I20, I21, I22, I23, I24). No speciﬁc validation of clinical
diagnosis or coding was undertaken and co-morbidity was not
explored.
Descriptive statistics are presented as frequencies (percentages) for
category data. The crude rate per million population (pmp), taking no
account of the age structure of the population, was calculated using
the census 2006 applied to the data for years 2004–2008 and census
2011 applied to the data for 2009–2011 (www.cso.ie). Discharge rates
were age-standardised to the European standard population and
calculated using the direct method for those aged 25–84 years.
Cochrane Armitage Trend test was used to compare proportions over
time. Crude ratios of numbers of PCI to angiography were calculated,
and examined over time using Poisson regression analysis. The statisti-
cal package, SAS (v9.1, SAS Institute, Cary, USA), was used for analysis
and signiﬁcance at p b 0.05 was assumed. Ethical approval was not re-
quired as all data were either aggregated (survey) or anonymised
(HIPE), the latter released under a conﬁdentiality agreement with the
ESRI.3. Results
In Ireland, the number of hospitals with catheterisation laboratories
increased from 12 in 2004 to 16 in 2011 with a greater increase in pri-
vate sector (Table 1). A further three public hospitals provided a limited
angiography only service usingmobile cardiac catheterisation laborato-
ries. A greater number of cases undergoing diagnostic angiography and
PCI were performed in the public sector throughout the study period,
although the proportion undergoing PCI in the public sector declined
signiﬁcantly from 76% (2004) to 66% (2011) (p b 0.001). The number
of hospitals undertaking ≤200 PCI procedures annually ﬂuctuated and
then decreased by 2011 (Table 1). However, the proportion of
hospitals performing a high volume of ≥400 PCIs per year decreased
from 67% (8 / 12) in 2004 to 50% (8 / 16) in 2011 with the public sector
hospitals (67%, 6 / 9) more likely to undertake high volumes then the
private sector (29%, 2 / 7).3.1. Demography
Patients undergoing angiography in the public sector (HIPE) in 2011
were younger (mean age 62 years) than PCI patients (mean age
63.2 years) with little change over the eight years in either group
(Table 1). Younger patients (under 65 years) were signiﬁcantly more
likely to undergo PCI over time (p= 0.012).Women,whether undergo-
ing angiography or PCI, were on average older than men (Table 1)
though the age gap was larger for PCI (4.4 years in 2011) compared to
angiography (2.4 years in 2011).While themajority of both procedures
were carried out on males (Table 1) the proportion was greater for
PCI and increasingly so over the eight years in the public sector
(p b 0.0001).3.2. Angiography and PCI to angiography ratio
Overall, angiography provision, on survey, in private and publicly
funded hospitals in Ireland increased from 4899 to 6689 crude rate
per million population (pmp) — an increase of 47.8% over the eight
years studied (Table 2).
However, allowing for demographic changes in the last decade in
Ireland the age standardised rate (ASR), using just HIPE data for publicly
funded hospitals accounting for 63% of provision in 2011, showed amore
modest, though signiﬁcant increase of 9.2% over time (p = 0.006). The
ASR rose signiﬁcantly over the time period in both those under and
over 65 years (Table 2).
The PCI to angiography ratio, on survey, decreased signiﬁcantly from
30% to 27% in the 8 years (p= 0.0015). This trend in fewer interventions
to diagnostic tests was signiﬁcant in private hospitals (p = 0.0003)
starting in 2008 to 2010 (Table 2) though not in publicly funded
hospitals. The lowest ratio was seen in 2010 in the private sector (22%).3.3. Percutaneous coronary intervention activity
PCI provision, on survey, increased at a population level in Ireland
from 1454 to 1825 per million population (pmp) — an increase of
35.9% in 8 years across public and private hospitals (Table 2). This
increasewasmoremarked in the private (75%) compared to the public-
ly funded (22%) sector.
However, while the crude rate per million increased, the age
standardised rate on HIPE analysis, accounting for 66% of 2011
provision, showed a non-signiﬁcant decrease (−6.8%) overall
(25–84 years) and in the younger population (under 65 years). In
the population aged 65 years and over (Table 2), on the other hand,
the decrease was signiﬁcant (p = 0.04) in this data from publically
funded hospitals. No gender pattern was found (M, p = 0.27 for the
trend; F, p = 0.051 for trend).
Table 1
Facilities, volume of activity and demographic data in those undergoing angiography and PCI.
2004 2005 2006 2007 2008 2009 2010 2011 p-Value
Facilities and volume
No of hosps with Cath labs
Public 8 8 8 8 9 9 9 9
Private 4 4 4 6 7 7 7 7
Total 12 12 12 14 16 16 16 16
No of hosps performing PCIs
Less than 200 3 1 0 2 5 2 1 2
200–399 1 4 5 5 4 7 7 6
400 and over 8 7 7 7 7 7 8 8
Demography (HIPE)
Angiography
Mean age 61.8 61.1 61.7 61.4 61.7 61.9 61.9 62.0 p = 0.11
Mean age (M) 61.1 60.7 61.2 60.9 61.2 61.3 61.3 61.4 p = 0.07
Mean age (F) 63.0 61.9 62.5 62.3 62.7 63.0 62.7 63.1 p = 0.24
% males 65.7% 63.2% 62.8% 64.0% 65.1% 64.9% 61.9% 65.4% p b 0.001
Demography (HIPE)
PCI
Mean age 63.2 63.2 62. 9 63.0 63.4 63.1 62.9 63.2 NS
Mean age (M) 62 62.2 61.7 61.9 62.3 62.1 62.0 62.2 NS
Mean age (F) 66.6 66.1 66.4 66.1 66.4 66.2 65.8 66.6 NS
% males 73.0% 74.0% 74.3% 74.7% 74.2% 75.5% 77.1% 76.7% p b 0.0001
% under 65 years 51.2% 51.0% 52.4% 52.1% 51.2% 52.7% 53.7% 52.8% p = 0.012
% under 65 years (M) 56.4% 55.6% 57.5% 57.3% 56.2% 57.2% 58.3% 57.1% p = 0.14
% under 65 years (F) 37.4% 38.8% 38.8% 38.9% 37.5% 39.0% 41.2% 38.6% p = 0.33
NS = non-signiﬁcant.
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similar with divergence only in last three years 2009–2011 with crude
rate showing an increase but ASR remaining stable (Fig. 1).
In patients aged 25–84 years HIPE analysis for publicly funded hos-
pitals showed PCI, performed on patients with coronary heart disease,
was carried out predominantly for stable disease (53.73% in 2011). PCI
was performed for ACS in 34.70% of cases in 2005 rising to 47.40% in
2009 with subsequent decline (Fig. 2).
4. Discussion
We found an increase in numbers and crude rate of coronary diag-
nostic and interventional procedures culminating in a PCI provision of
1825 per million population (pmp) in 2011 in context of expansion in
the cardiac interventional capacity in Ireland. Following age adjustment,
however, PCI activity showed a decrease from 2004 to 2011 signiﬁcant
in those aged 65 years and over. Males were more likely to undergo
PCI than females. There is a trend towards more diagnostic procedures
compared with interventions over time, signiﬁcantly increased in theTable 2
Trend in angiography, PCI and PCI to angiography ratio, 2004–2011, Ireland.
2004 2005 2006 2007
Angiography numbers (survey) 20,770 22,874 24,479 25,67
Crude rate per million (survey) 4899 5395 5774 605
Angiography numbers (HIPE) 13,929 13,497 14,874 15,21
ASR 25–84 (HIPE) 592.3 557.5 601.5 59
ASR b 65 years (HIPE) 408.7 386.6 403.8 40
ASR 65+ years (HIPE) 1565.3 1463.0 1651.6 163
PCI numbers (survey) 6163 6819 7253 696
Crude rate per million (survey) 1454 1608 1711 164
PCI % public provision (survey) 76% 69% 68% 64
PCI numbers (HIPE) 4189 4372 4513 429
PCI ASR 25–84 (HIPE) 177.4 179.5 182.3 16
PCI ASR b 65 years (HIPE) 114.2 114.6 118.1 10
PCI ASR 65+ years (HIPE) 512.3 523.4 522.3 49
PCI: angiography ratio
Public hosps (survey) 30.6% 30.5% 30.3% 2
Private hosps (survey) 27.5% 28.3% 28.3% 2
Total 29.7% 29.8% 29.6% 2private sector, resulting in an overall PCI to angiography ratio of
27.38% in 2011. Variation in volume of PCI per centre occurred due in
part to expansion of the number of cardiac catheterisation facilities,
though only half of the hospitals undertook a high volume of ≥400
PCIs per year in 2011. One third of diagnostic and interventional provi-
sion occurred in the private sector and was not captured in the routine
administrative data sets.
The increase in provision of coronary diagnostic and interventional
procedures in Ireland should be seen in the context of a country
which had the highest premature death rate from CHD in the EU in
the 1990s. In 1999 the ﬁrst national heart strategy, Building Healthier
Hearts [9], was published and among its recommendations was to in-
crease PCI provision in Ireland to a target of 1200 pmp by 2002. Our
ﬁnding of 1825 pmp in 2011 demonstrates a sizeable increase on that
target and is comparable to the current OECD average across 21 EU
countries of 1910 pmp [12]. Furthermore our ﬁnding is remarkably
similar to that reported for Northern Ireland of 1751 pmp though higher
than the UK rate of 1405 pmp [13]. Comparison with the USA is difﬁcult
due, in the main, to different reporting methodologies. However one2008 2009 2010 2011 p-Value
6 25,754 27,819 30,587 30,690
6 6074 6063 6666 6689
5 16,073 16,529 18,008 18,388
7.6 612.3 610.9 649.7 646.8 p = 0.006
2.6 407.1 402.4 435.2 431.6 p = 0.04
0.7 1699.9 1716.1 1786.7 1787.5 p = 0.003
7 6878 7187 8123 8373
3 1622 1566 1770 1825
% 65% 66% 68% 66% p b 0.001
3 4321 4465 4933 4741
8.5 179.4 164.7 176.7 165.9 p = 0.131
7.7 113.0 107.2 117.8 109.6 p = 0.46
0.9 531.1 469.5 488.7 464.6 p = 0.044
7.0% 27.7% 27.3% 29.4% 28.5% p = 0.12
7.3% 25.0% 23.3% 22.1% 25.3% p = 0.0003
7.1% 26.7% 25.8% 26.6% 27.3% p = 0.0015
Fig. 1.Trend in age standardised rate (ASR) permillion (95% CI) onHIPE and crude rate per
million on survey, 2004–2011.
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2980 pmp in 2009 [14] and the OECD noted a crude rate in the USA
(2009) of 3770 pmp [15].
The ﬁnding of a consistently increasing trend in crude rate per
million population in PCI provision in Ireland over the eight years has
also been reported in the UK [13] up to 2011. Similarly the OECD docu-
ments an increase in crude rate of PCI provision in all contributing coun-
tries for the period 2000 to 2010 averaging 9.4% overall [12]. However
the crude rate takes no account of the age structure of a population, a
particularly important feature in comparing across countries at different
stages in the CHD epidemic. Following age adjustmentwe report a non-
signiﬁcant decreasing trend in the PCI rate in Ireland. While data from
the USA [5,14,16] has reported this decreasing trend from the mid-
2000 onwards and two recent studies [17,18] have noted stable rates
we are not aware of any other attention given to this trend especially
in Europe.
The trend towards fewer interventions to angiography seen in both
private and publicly funded hospitals in Ireland is in contrast to reports
from the USA [14] and the UK [13]. The greater application of non-
invasive functional and anatomic imaging (stress echocardiography,
stress perfusion scintigraphy and CT angiography) may account for
some reduction in invasive angiography in the USA [19]. Also recogni-
tion of the low yield of diagnostic coronary angiography performed in
lower risk patients, emphasised in the latest ESC guideline for manage-
ment of stable coronary artery disease [4], may contribute to falling
numbers in some countries [20].
The COURAGE trial in 2007 demonstrated that a strategy of PCI as
initial therapy in patients with stable disease was not superior toFig. 2. Trend in percentage (95% CI) clinical indication (acute or non-acuteoptimal medical therapy [2]. Subsequently a number of US studies
have shown a signiﬁcant and sustained decline in the use of PCI to
treat patients with stable angina [21,22]. In 2012 a similar trendwas re-
ported in the UK, with two thirds of PCIs undertaken for acute disease
[23]. It is difﬁcult to explain our ﬁndings of a limited increase in the pro-
portion of PCIs undertaken for acute disease from 2005 to 2009 with a
fall off thereafter. The historical context of a country with high CHD
mortality and late, though rapid, expansion in provision of intervention-
al cardiology after the 1999 strategy, is likely to be a factor in the in-
creased number of procedures but does not account for the
predominance of interventions for stable disease. Furthermore, while
the expansion was greatest in the private sector accounting for one
third of provision, no data is available for analysis of the clinical indica-
tion in this patient group posing problems in assessing the complete na-
tional picture. Nonetheless it seems likely that an even greater
proportion of PCI performed in the private sector will have been for sta-
ble disease, given the clinical proﬁle of patients admitted toprivate facil-
ities and the fact that most private facilities did not have emergency
facilities until the late 2000s. Lastly, a failure to accept or apply the im-
plications of new evidence from contemporary trials such as
COURAGE [2] and FREEDOM [24] may contribute to continued dispro-
portionately high rates of PCI in the population with stable coronary
artery disease.
With an increase in PCI provision in Ireland there has been a
decrease in centres undertaking very low volume. The optimal mini-
mum standard of 400 PCIs per facility advocated in the USA [25] and
in the UK [13] was met in half of the Irish institutions and compares
favourably with 51% in USA in 2012 [26] and 65% (NHS and private) in
the 2012 BCIS audit [23].
There is little recent published data on trends in interventional car-
diology outside North America [5,14,16,18] and a paper from Sweden
[17]. Our study is the ﬁrst to our knowledge to report temporal trends
in angiography and PCI combining private and public statistics across
a population in Europe. Further it is the ﬁrst to use and compare crude
and age standardised rate trends in diagnostic and interventional cardi-
ology, highlighting the limitations of the former approach which con-
tinues to be the most common methodology in existing reports of PCI
in Europe. Using two data sources a fuller picture of a treatment in evo-
lution is available for Ireland and accordingly updates and corrects the
international record of Irish PCI provision by the OECD in 2012 (900
pmp) [12] and Eurostat 2009 (836 pmp) [27].
The study ﬁndings should be viewed in light of some limitations. Of
the two data sources one involved collating aggregate survey data with
no attempt at detailed deﬁnitions and therefore possible variation in
quality of submitted information. Nonetheless this survey clariﬁes the
total number of procedures across public and privately funded hospitalsdisease) for PCI in patients admitted with CHD, 2005–2011 in Ireland.
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age, gender and diagnosis but only two thirds of the population were
admitted to public hospitals leaving a signiﬁcant gap in our knowledge
of the characteristics of the other one third in the private sector. In spite
of quality control mechanisms in place for the HIPE process, we found
variability across hospitals in coding angiography in patients who had
a subsequent PCI in the earlier years 2004–2006.
With increasing survival and ageing populations,many countries are
undergoing considerable health services reform. In addition, Ireland has
a relatively high prevalence of obesity, diabetes and other chronic
diseases in middle and older age groups [28]. From 2008 onwards the
country experienced a sharp economic downturn, with increased un-
employment and associated risks to cardiovascular health. It is impor-
tant to consider trends in coronary interventions against that
background and to address the deﬁcits in health information identiﬁed
in our study.
We ﬁnd very little comparative interventional cardiology surveil-
lance outside of North America. With a changing and costly clinical
activity there is a need formore prospective data collection and system-
atic surveillance methodologies, as envisaged with the CARDS [29] ini-
tiative during the 2004 EU Presidency, to understand current rate of
uptake of an expensive technology, to promote implementation of the
evidence and to facilitate international comparison. Our ﬁndings and
subsequent deliberations may assist the recently formed ESC Task
Force on CVD data standardisation as well as the inventory of registries
[30].
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